Computer Aided Detection Market By Application (Oncology, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer), By Imaging Modality (Mammography, MRI, CT, Tomosynthesis), By Region - Global Market Insights 2020 to 2025

Computer Aided Detection Market on a Dexterous Growth Trajectory on Back of Rapid Detection of Debilitating Diseases

Computer aided assistance in medical sciences has existed for a long time. Since the last two decades, doctors, researchers and practitioners have been using medical imaging devices that are integrated with computer aided detection (CADe) or computer aided diagnosis (CADx).

The demand for such assistance arose from the increasing need for expert inferences. Computer aided detection has been used to increase sensitivity of diagnostic imaging in case of medical investigation and differential diagnostics.

Computer aided detections enable timely detection of debilitating diseases such as cancer.

This has motivated patients to opt for random tests and checkups. On the back of these trends, the global computer aided detection market is anticipated to register imminent growth opportunities in the future.

The market is foreseen to expand at a healthy CAGR of 9.8% during the forecast period (2020-2025), surpassing a value of US$ 1.1 Bn.

Mammography to Capture Lucrative Share, Tomosynthesis to Expand Impressively

Mammography procedures are forecast to utilize significant computer aided detection procedures in the future. This is attributed to rising incidences of breast cancer among women.

Mammography is majorly performed for two purposes: diagnostic and simple screening for genetic traits of breast cancer. Also, images from breast cancer can be manipulated for better views and stored easily.

The segment is anticipated to register a staggering CAGR of 8.3%, capturing over two-fifth of the overall computed aided detection market.

The tomosynthesis segment is projected to expand rapidly throughout the forecast period. Rising adoption of digital breast tomosynthesis is attributed to the fact that it provides a high-contrast image and accuracy.

The radiation is more concentrated and imaging of the entire breast is performed with a limited degree scan. Also, evaluation of dense breasts and lesion contour by tomosynthesis is more sensitive than a mammography.

An impressive CAGR of 13.6% is projected for the tomosynthesis segment during the forecast period.

North America Poised to Remain Dominant, Asia-Pacific to Experience Burgeoning Growth

North America is anticipated to dominate the global computer aided detection market, owing to increasing incidences of breast cancer.

Development of advanced breast cancer imaging techniques, combined with increase in awareness about early breast cancer screening are also anticipated to drive the North American market forward.

Projections indicate a market share amounting to more than half of the overall North American computer aided detection market.

Asia-Pacific is anticipated to be the most attractive market for computer aided detection technologies.

A large patient pool, owing to a huge population base and subsequent incidences of diseases shall propel market growth.

Moreover, affordable investment costs has motivated key manufacturers to increase their scale of operations, thus boosting the computer aided detection market. A staggering CAGR of 14.3% is predicted for the Asia-Pacific market.

Investment in Digital Solutions Pave Way for Competitive Edge

The global computer aided detection market is largely consolidated. The top five players:

• Hologic Inc.
• GE Healthcare
• Invio Corporation
• Siemens Healthcare 
• Agfa-Gevaert N.V.,

account for almost three-quarters of the market. Out of these, Hologic, Inc., dominates the computer aided detection market.

A diversified product portfolio, extensive geographical presence and acquisition strategies has enabled it to retain market presence.

The company offers digital mammography solutions through its Selenia, SecureView, Trident Specimen Radiography System and Digital SteroLoc.

GE Healthcare accounts for the second largest share in the computer aided detection market. The company provides diagnostic imaging solutions, healthcare IT solutions, radiography and fluoroscopy.

Its mammography systems include SenoClaire, SenoBright CESM and Pristina Serena 3D devices.

The third player, Agfa-Gevaert N.V. offers IT and digital imaging solutions and distributes them to healthcare industries. It offers digital radiography services through its CR-10-X, CR-12-X, CR-15-X and CR-30-X platforms respectively.

In addition, Agfa also offers mammography solutions via the MAMORAY HDR C-PLUS FILM which offers exceptional mammography image quality. It is equipped with the Cubic Crystal Technology which minimizes noise and enhances image consistency.

Global Computer Aided Detection Market Segmentation

Fact.MR has studied the global computer aided detection market with detailed segmentation on the basis of application, imaging modality and key regions.

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”